2015-2016 Session
Change SessionHouse Committee on Health Care (Room 45)
The House Committee on Health Care considers matters relating to health care finance and administration.
- Meeting Schedule
-
- No meeting is currently scheduled
- Previous Meetings
Documents & Handouts
Browse documents below or use document search.
Materials posted on this page are for informational purposes only and may not include all material received by the Committee. The Committee is not responsible for the accuracy of posted material, and posting does not represent approval or endorsement by the Committee or the Vermont General Assembly.
- Back
- Documents/2016/WorkGroups/House Health Care/Bills/H.866
- Thursday, April 21, 2016
- Wednesday, April 20, 2016
- Monday, April 18, 2016
- Friday, April 15, 2016
- Thursday, April 14, 2016
- Wednesday, April 6, 2016
- Tuesday, April 5, 2016
- H.866: Bill Lippert: Reuters Report, 4-4-16- Makers took big price increases on widely used U.S. drugs
- H.866: Reshma Ramachandran: Letter from the National Physicians Alliance—Support the Pharmaceutical Cost Transparency Act of 2015
- H.866: Reshma Ramachandran: Report--Medicines Use and Spending Shifts
- H.866: Reshma Ramachandran: Report--Spending on Medicines Increased 13.1 Percent in 2014
- Thursday, March 31, 2016
- H.866: Jim McCullough: Amendment re Complementary and Alternative Medicine
- H.866: Jim McCullough: CAM and Integrative Health Reduce Pharmaceutical Utilization
- H.866: Jim McCullough: Testimony on Complementary and Alternative Medicine
- H.866: Leigh Purvis: AARP- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans
- H.866: Leigh Purvis: Biography, Leigh Purvis
- H.866: Ritchard Engelhardt: Testimony of the Biotechnology Innovation Organization (BIO)
- H.866: Susan Barrett: Follow-up information, re GMCB subpoena authority in statutes
- Wednesday, March 30, 2016
- H.866: James Love: Increasing the Transparency of Markets for Drugs, Vaccines, Diagnostics and Other Medical Technologies
- H.866: James Love: When governments mandate transparency of RandD costs, the details are important
- H.866: John Murphy: PhRMA--Innovative Biopharmaceutical Companies Disclose Wide Range of Data on Their Products
- Wednesday, March 23, 2016
- Friday, March 18, 2016
- Friday, March 11, 2016
- Tuesday, March 8, 2016
- Tuesday, February 23, 2016
- Tuesday, February 16, 2016
- Thursday, February 4, 2016
- Friday, January 22, 2016
- Thursday, January 21, 2016
- Back
Bills In House Committee on Health Care
Bills that are currently in committee.
2015 - 2016 Legislative Session
Bill | Title | Sponsor |
---|
Bills Out of House Committee on Health Care
Bills sponsored by the committee, and bills reported out of committee. Includes bills where the committee has been relieved of responsibility.
2015 - 2016 Legislative Session
Bill | Title | Sponsor | Act # | Year |
---|
Bills Referred to House Committee on Health Care
Bills that were in committee at any time. Does not include bills sponsored by Committee.
2015 - 2016 Legislative Session
Bill | Title | Sponsor | Act # | Year |
---|
Bills Sponsored by House Committee on Health Care
2015 - 2016 Legislative Session
Bill | Title | Act # |
---|
Legislative language and other materials posted on this page are subject to frequent change and may not reflect the Committee's most recent discussions or actions. Please check back often for updated materials.